First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004. (Q33869371)

29 July 2017

0 references

First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004. (English)

1 reference

eradication of infectious diseases

29 July 2017

1 reference

1 reference

1 reference

György M Buzás

1

1 reference

PubMed ID

16981260

29 July 2017

Jolán Józan

series ordinal

2

1 reference

PubMed ID

16981260

29 July 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

World Journal of Gastroenterology

29 July 2017

1 reference

29 July 2017

12

1 reference

29 July 2017

33

1 reference

29 July 2017

5311-5319

1 reference

Helicobacter pylori infection: treatment options.

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta‐analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Development and evaluation of a quality score for abstracts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088197

Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

5 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I33.5311

The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I33.5311

Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I33.5311

Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I33.5311

Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report

21 January 2018

1 reference

12 December 2020

Antimicrobial treatment of H. pylori infection--a pooled efficacy analysis of eradication therapies

1 reference

12 December 2020

Evaluation of treatment regimens to cure Helicobacter pylori infection--a meta-analysis

1 reference

12 December 2020

Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains

1 reference

12 December 2020

Treatment of Helicobacter pylori

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I33.5311

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

PubMed ID

16981260